Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Women are more likely to have long-term post-COVID symptoms than men.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

New techniques have improved acne scar treatment, but multiple tailored sessions are often needed.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Overexpression of SSAT in mice causes hair loss, liver damage, and sensitivity to polyamine analogues.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Over 25% of COVID-19 patients had symptoms lasting more than a year.

An unhealthy scalp can damage new hair, but using ZPT shampoo can improve hair health.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Elderly men with a scalp condition healed in about 26 days using specific creams and dressings, with no return of the condition in 6 months.

Finasteride can cause serious physical, mental, and sexual side effects, even after stopping the treatment.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Finasteride for female hair loss has low side effects, more research needed.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Gene expression differences in PFS patients suggest a potential organic cause for symptoms.

Microneedling with platelet-rich plasma helps dog hair regrow faster than microneedling alone.

Using tissue expanders with galeotomies for post-burn alopecia is faster and has fewer complications.